Philip Lee Healthcare, Pharmaceutical and Life Sciences Q4 2023

Key Contacts: Ronan Dunne – Partner  | Marie Kinsella – Partner

Welcome to the latest update from the Philip Lee Healthcare, Pharmaceutical and Life Sciences group in respect of the fourth quarter of 2023.

To read the full article click here.

For further information in relation to this article please contact Ronan Dunne or Marie Kinsella.

News and insights

Ireland’s M&A pipeline: experts predict a rebound in 2024

Ireland’s M&A pipeline: experts predict a rebound in 2024

Key Contacts: Eoghan Doyle - Partner Corporate partner Eoghan Doyle featured in the Sunday Business Post at the weekend, commenting on the M&A activity from 2023 and what he predicts for Ireland in 2024. “Ireland will continue to represent a strong value...

read more
Ireland’s M&A pipeline: experts predict a rebound in 2024

Regulation of foreign investment in Ireland

Key Contacts: Ronan Dunne - Partner Partner and head of EU and competition, Ronan Dunne, was pleased to contribute a practice note to Thomson Reuters Practical Law setting out the proposed legal regime for governing foreign investment in Ireland, once the Screening of...

read more
Ireland’s M&A pipeline: experts predict a rebound in 2024

Competition law bears down on Uefa and Fifa

Key Contacts: Ronan Dunne - Partner Partner and head of competition and state aid, Ronan Dunne featured in the Irish Examiner on Friday 29 December 2023, discussing the European Court of Justice judgment on the proposed European Super League. Read the article here....

read more
Share This